星空体育官方入口网站网址大全-登录入口官网

[GetPortalCommentsPageByObjectIdResponse(id=2096343, encodeId=b3f82096343d1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑血管疾病 经验分享：正在准备下一篇文章，再次用到这个系统决定写点经验回馈大家。临床小硕，一篇脑血管方面的文章。一审40天，审稿意见中肯严谨；按审稿意见修改15天后修回，20天后accept，差不多两个半月后online。研究生的第一篇文章，可以选择非OA不要版面费，现影响因子见长，目前2.667。加油吧医学僧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/d6e0b113f3f375444106bd57c5f62af3.jpg, createdBy=03155285285, createdName=V哈哈静, createdTime=Wed Oct 26 21:26:04 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147962, encodeId=fd48214e9626d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中;康复 经验分享：我师兄是雪落的誓言哈哈哈，我跟着他投的期刊。具体时间线：5月31日提交。6月02日 With Editor。6月05日 Under Review（邀请3，接受评审2）。6月26日RRC。6月26日 Major Revise（6条意见）。 7月07日提交修订，7月09日 With Editor，7月11日 Under Review（邀请1，接受评审1）。7月13日RRC。7月14日 Accept。一定要按照修改意见一条一条修改！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f78245022, createdName=ms6000000472127135, createdTime=Fri Jul 14 08:24:54 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2163616, encodeId=bc19216361616, content=请问下最近有投过综述的吗？投稿页面已经没有了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=136b8171073, createdName=ms9000000725000927, createdTime=Wed Oct 18 21:18:43 CST 2023, time=2023-10-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1231312, encodeId=f26612313122e, content=偏重的研究方向：房颤;心血管 经验分享：投稿后With Editor 4天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220708/c81f7dd923c54b8e84fe4716ff9fb706/a82b7266897b4d8c993cc7394b5d6767.jpg, createdBy=80462347615, createdName=122a44d6m85(暂无昵称), createdTime=Fri Jul 08 12:36:25 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138764, encodeId=db362138e640d, content=偏重的研究方向：脑血管;纯生信 经验分享：这个杂志对于纯生信的文章接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23cd8712869, createdName=ms7000000275097926, createdTime=Wed May 24 09:41:04 CST 2023, time=2023-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2139535, encodeId=35562139535ee, content=请问，最近有投这个杂志的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aaf8719470, createdName=ms2000000542857947, createdTime=Sun May 28 18:19:26 CST 2023, time=2023-05-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=571817, encodeId=39005e181781, content=审稿速度:1.0 经验分享：脑卒中病例对照研究。5.21 开始under review，6.2收到拒稿通知，只有一个审稿人，认为样本量太少，关联存在偶然性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee72530812, createdName=124ff737m56(暂无昵称), createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526443, encodeId=f4ab52644379, content=请问这个杂志接受脑血管病的实验文章不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac31694476, createdName=1de67449m99(暂无匿称), createdTime=Mon Aug 29 00:54:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554936, encodeId=743655493684, content=文章被接收了，修了2次，意见中肯，效率高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeOZwicjtKoFKia290ACJ5ic0JDJsfdTN5x3tqQKngx4zCfyc2O6pQkdEDlmXLaqKqCPwLvRaox0iaBg/132, createdBy=f6562183328, createdName=1207a24em51(暂无昵称), createdTime=Fri Apr 13 11:44:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113521, encodeId=af422113521a9, content=投稿时怎么默认通讯作者是一作呢？不能自己选啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054d5421182, createdName=ms4000000973281563, createdTime=Tue Feb 07 19:27:47 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆)]

2022-10-26 V哈哈静

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：脑血管疾病
经验分享：正在准备下一篇文章，再次用到这个系统决定写点经验回馈大家。临床小硕，一篇脑血管方面的文章。一审40天，审稿意见中肯严谨；按审稿意见修改15天后修回，20天后accept，差不多两个半月后online。研究生的第一篇文章，可以选择非OA不要版面费，现影响因子见长，目前2.667。加油吧医学僧！

90 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2096343, encodeId=b3f82096343d1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑血管疾病 经验分享：正在准备下一篇文章，再次用到这个系统决定写点经验回馈大家。临床小硕，一篇脑血管方面的文章。一审40天，审稿意见中肯严谨；按审稿意见修改15天后修回，20天后accept，差不多两个半月后online。研究生的第一篇文章，可以选择非OA不要版面费，现影响因子见长，目前2.667。加油吧医学僧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/d6e0b113f3f375444106bd57c5f62af3.jpg, createdBy=03155285285, createdName=V哈哈静, createdTime=Wed Oct 26 21:26:04 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147962, encodeId=fd48214e9626d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中;康复 经验分享：我师兄是雪落的誓言哈哈哈，我跟着他投的期刊。具体时间线：5月31日提交。6月02日 With Editor。6月05日 Under Review（邀请3，接受评审2）。6月26日RRC。6月26日 Major Revise（6条意见）。 7月07日提交修订，7月09日 With Editor，7月11日 Under Review（邀请1，接受评审1）。7月13日RRC。7月14日 Accept。一定要按照修改意见一条一条修改！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f78245022, createdName=ms6000000472127135, createdTime=Fri Jul 14 08:24:54 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2163616, encodeId=bc19216361616, content=请问下最近有投过综述的吗？投稿页面已经没有了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=136b8171073, createdName=ms9000000725000927, createdTime=Wed Oct 18 21:18:43 CST 2023, time=2023-10-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1231312, encodeId=f26612313122e, content=偏重的研究方向：房颤;心血管 经验分享：投稿后With Editor 4天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220708/c81f7dd923c54b8e84fe4716ff9fb706/a82b7266897b4d8c993cc7394b5d6767.jpg, createdBy=80462347615, createdName=122a44d6m85(暂无昵称), createdTime=Fri Jul 08 12:36:25 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138764, encodeId=db362138e640d, content=偏重的研究方向：脑血管;纯生信 经验分享：这个杂志对于纯生信的文章接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23cd8712869, createdName=ms7000000275097926, createdTime=Wed May 24 09:41:04 CST 2023, time=2023-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2139535, encodeId=35562139535ee, content=请问，最近有投这个杂志的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aaf8719470, createdName=ms2000000542857947, createdTime=Sun May 28 18:19:26 CST 2023, time=2023-05-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=571817, encodeId=39005e181781, content=审稿速度:1.0 经验分享：脑卒中病例对照研究。5.21 开始under review，6.2收到拒稿通知，只有一个审稿人，认为样本量太少，关联存在偶然性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee72530812, createdName=124ff737m56(暂无昵称), createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526443, encodeId=f4ab52644379, content=请问这个杂志接受脑血管病的实验文章不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac31694476, createdName=1de67449m99(暂无匿称), createdTime=Mon Aug 29 00:54:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554936, encodeId=743655493684, content=文章被接收了，修了2次，意见中肯，效率高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeOZwicjtKoFKia290ACJ5ic0JDJsfdTN5x3tqQKngx4zCfyc2O6pQkdEDlmXLaqKqCPwLvRaox0iaBg/132, createdBy=f6562183328, createdName=1207a24em51(暂无昵称), createdTime=Fri Apr 13 11:44:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113521, encodeId=af422113521a9, content=投稿时怎么默认通讯作者是一作呢？不能自己选啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054d5421182, createdName=ms4000000973281563, createdTime=Tue Feb 07 19:27:47 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆)]

2023-07-14 ms6000000472127135 来自广东省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：脑卒中;康复
经验分享：我师兄是雪落的誓言哈哈哈，我跟着他投的期刊。具体时间线：5月31日提交。6月02日 With Editor。6月05日 Under Review（邀请3，接受评审2）。6月26日RRC。6月26日 Major Revise（6条意见）。 7月07日提交修订，7月09日 With Editor，7月11日 Under Review（邀请1，接受评审1）。7月13日RRC。7月14日 Accept。一定要按照修改意见一条一条修改！！！

63 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2096343, encodeId=b3f82096343d1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑血管疾病 经验分享：正在准备下一篇文章，再次用到这个系统决定写点经验回馈大家。临床小硕，一篇脑血管方面的文章。一审40天，审稿意见中肯严谨；按审稿意见修改15天后修回，20天后accept，差不多两个半月后online。研究生的第一篇文章，可以选择非OA不要版面费，现影响因子见长，目前2.667。加油吧医学僧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/d6e0b113f3f375444106bd57c5f62af3.jpg, createdBy=03155285285, createdName=V哈哈静, createdTime=Wed Oct 26 21:26:04 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147962, encodeId=fd48214e9626d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中;康复 经验分享：我师兄是雪落的誓言哈哈哈，我跟着他投的期刊。具体时间线：5月31日提交。6月02日 With Editor。6月05日 Under Review（邀请3，接受评审2）。6月26日RRC。6月26日 Major Revise（6条意见）。 7月07日提交修订，7月09日 With Editor，7月11日 Under Review（邀请1，接受评审1）。7月13日RRC。7月14日 Accept。一定要按照修改意见一条一条修改！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f78245022, createdName=ms6000000472127135, createdTime=Fri Jul 14 08:24:54 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2163616, encodeId=bc19216361616, content=请问下最近有投过综述的吗？投稿页面已经没有了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=136b8171073, createdName=ms9000000725000927, createdTime=Wed Oct 18 21:18:43 CST 2023, time=2023-10-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1231312, encodeId=f26612313122e, content=偏重的研究方向：房颤;心血管 经验分享：投稿后With Editor 4天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220708/c81f7dd923c54b8e84fe4716ff9fb706/a82b7266897b4d8c993cc7394b5d6767.jpg, createdBy=80462347615, createdName=122a44d6m85(暂无昵称), createdTime=Fri Jul 08 12:36:25 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138764, encodeId=db362138e640d, content=偏重的研究方向：脑血管;纯生信 经验分享：这个杂志对于纯生信的文章接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23cd8712869, createdName=ms7000000275097926, createdTime=Wed May 24 09:41:04 CST 2023, time=2023-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2139535, encodeId=35562139535ee, content=请问，最近有投这个杂志的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aaf8719470, createdName=ms2000000542857947, createdTime=Sun May 28 18:19:26 CST 2023, time=2023-05-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=571817, encodeId=39005e181781, content=审稿速度:1.0 经验分享：脑卒中病例对照研究。5.21 开始under review，6.2收到拒稿通知，只有一个审稿人，认为样本量太少，关联存在偶然性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee72530812, createdName=124ff737m56(暂无昵称), createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526443, encodeId=f4ab52644379, content=请问这个杂志接受脑血管病的实验文章不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac31694476, createdName=1de67449m99(暂无匿称), createdTime=Mon Aug 29 00:54:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554936, encodeId=743655493684, content=文章被接收了，修了2次，意见中肯，效率高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeOZwicjtKoFKia290ACJ5ic0JDJsfdTN5x3tqQKngx4zCfyc2O6pQkdEDlmXLaqKqCPwLvRaox0iaBg/132, createdBy=f6562183328, createdName=1207a24em51(暂无昵称), createdTime=Fri Apr 13 11:44:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113521, encodeId=af422113521a9, content=投稿时怎么默认通讯作者是一作呢？不能自己选啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054d5421182, createdName=ms4000000973281563, createdTime=Tue Feb 07 19:27:47 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆)]

2023-10-18 ms9000000725000927 来自四川省

请问下最近有投过综述的吗？投稿页面已经没有了

63 0

[GetPortalCommentsPageByObjectIdResponse(id=2096343, encodeId=b3f82096343d1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑血管疾病 经验分享：正在准备下一篇文章，再次用到这个系统决定写点经验回馈大家。临床小硕，一篇脑血管方面的文章。一审40天，审稿意见中肯严谨；按审稿意见修改15天后修回，20天后accept，差不多两个半月后online。研究生的第一篇文章，可以选择非OA不要版面费，现影响因子见长，目前2.667。加油吧医学僧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/d6e0b113f3f375444106bd57c5f62af3.jpg, createdBy=03155285285, createdName=V哈哈静, createdTime=Wed Oct 26 21:26:04 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147962, encodeId=fd48214e9626d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中;康复 经验分享：我师兄是雪落的誓言哈哈哈，我跟着他投的期刊。具体时间线：5月31日提交。6月02日 With Editor。6月05日 Under Review（邀请3，接受评审2）。6月26日RRC。6月26日 Major Revise（6条意见）。 7月07日提交修订，7月09日 With Editor，7月11日 Under Review（邀请1，接受评审1）。7月13日RRC。7月14日 Accept。一定要按照修改意见一条一条修改！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f78245022, createdName=ms6000000472127135, createdTime=Fri Jul 14 08:24:54 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2163616, encodeId=bc19216361616, content=请问下最近有投过综述的吗？投稿页面已经没有了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=136b8171073, createdName=ms9000000725000927, createdTime=Wed Oct 18 21:18:43 CST 2023, time=2023-10-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1231312, encodeId=f26612313122e, content=偏重的研究方向：房颤;心血管 经验分享：投稿后With Editor 4天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220708/c81f7dd923c54b8e84fe4716ff9fb706/a82b7266897b4d8c993cc7394b5d6767.jpg, createdBy=80462347615, createdName=122a44d6m85(暂无昵称), createdTime=Fri Jul 08 12:36:25 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138764, encodeId=db362138e640d, content=偏重的研究方向：脑血管;纯生信 经验分享：这个杂志对于纯生信的文章接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23cd8712869, createdName=ms7000000275097926, createdTime=Wed May 24 09:41:04 CST 2023, time=2023-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2139535, encodeId=35562139535ee, content=请问，最近有投这个杂志的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aaf8719470, createdName=ms2000000542857947, createdTime=Sun May 28 18:19:26 CST 2023, time=2023-05-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=571817, encodeId=39005e181781, content=审稿速度:1.0 经验分享：脑卒中病例对照研究。5.21 开始under review，6.2收到拒稿通知，只有一个审稿人，认为样本量太少，关联存在偶然性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee72530812, createdName=124ff737m56(暂无昵称), createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526443, encodeId=f4ab52644379, content=请问这个杂志接受脑血管病的实验文章不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac31694476, createdName=1de67449m99(暂无匿称), createdTime=Mon Aug 29 00:54:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554936, encodeId=743655493684, content=文章被接收了，修了2次，意见中肯，效率高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeOZwicjtKoFKia290ACJ5ic0JDJsfdTN5x3tqQKngx4zCfyc2O6pQkdEDlmXLaqKqCPwLvRaox0iaBg/132, createdBy=f6562183328, createdName=1207a24em51(暂无昵称), createdTime=Fri Apr 13 11:44:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113521, encodeId=af422113521a9, content=投稿时怎么默认通讯作者是一作呢？不能自己选啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054d5421182, createdName=ms4000000973281563, createdTime=Tue Feb 07 19:27:47 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆)]

2022-07-08 122a44d6m85(暂无昵称)

偏重的研究方向：房颤;心血管
经验分享：投稿后With Editor 4天了

72 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2096343, encodeId=b3f82096343d1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑血管疾病 经验分享：正在准备下一篇文章，再次用到这个系统决定写点经验回馈大家。临床小硕，一篇脑血管方面的文章。一审40天，审稿意见中肯严谨；按审稿意见修改15天后修回，20天后accept，差不多两个半月后online。研究生的第一篇文章，可以选择非OA不要版面费，现影响因子见长，目前2.667。加油吧医学僧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/d6e0b113f3f375444106bd57c5f62af3.jpg, createdBy=03155285285, createdName=V哈哈静, createdTime=Wed Oct 26 21:26:04 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147962, encodeId=fd48214e9626d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中;康复 经验分享：我师兄是雪落的誓言哈哈哈，我跟着他投的期刊。具体时间线：5月31日提交。6月02日 With Editor。6月05日 Under Review（邀请3，接受评审2）。6月26日RRC。6月26日 Major Revise（6条意见）。 7月07日提交修订，7月09日 With Editor，7月11日 Under Review（邀请1，接受评审1）。7月13日RRC。7月14日 Accept。一定要按照修改意见一条一条修改！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f78245022, createdName=ms6000000472127135, createdTime=Fri Jul 14 08:24:54 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2163616, encodeId=bc19216361616, content=请问下最近有投过综述的吗？投稿页面已经没有了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=136b8171073, createdName=ms9000000725000927, createdTime=Wed Oct 18 21:18:43 CST 2023, time=2023-10-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1231312, encodeId=f26612313122e, content=偏重的研究方向：房颤;心血管 经验分享：投稿后With Editor 4天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220708/c81f7dd923c54b8e84fe4716ff9fb706/a82b7266897b4d8c993cc7394b5d6767.jpg, createdBy=80462347615, createdName=122a44d6m85(暂无昵称), createdTime=Fri Jul 08 12:36:25 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138764, encodeId=db362138e640d, content=偏重的研究方向：脑血管;纯生信 经验分享：这个杂志对于纯生信的文章接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23cd8712869, createdName=ms7000000275097926, createdTime=Wed May 24 09:41:04 CST 2023, time=2023-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2139535, encodeId=35562139535ee, content=请问，最近有投这个杂志的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aaf8719470, createdName=ms2000000542857947, createdTime=Sun May 28 18:19:26 CST 2023, time=2023-05-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=571817, encodeId=39005e181781, content=审稿速度:1.0 经验分享：脑卒中病例对照研究。5.21 开始under review，6.2收到拒稿通知，只有一个审稿人，认为样本量太少，关联存在偶然性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee72530812, createdName=124ff737m56(暂无昵称), createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526443, encodeId=f4ab52644379, content=请问这个杂志接受脑血管病的实验文章不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac31694476, createdName=1de67449m99(暂无匿称), createdTime=Mon Aug 29 00:54:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554936, encodeId=743655493684, content=文章被接收了，修了2次，意见中肯，效率高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeOZwicjtKoFKia290ACJ5ic0JDJsfdTN5x3tqQKngx4zCfyc2O6pQkdEDlmXLaqKqCPwLvRaox0iaBg/132, createdBy=f6562183328, createdName=1207a24em51(暂无昵称), createdTime=Fri Apr 13 11:44:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113521, encodeId=af422113521a9, content=投稿时怎么默认通讯作者是一作呢？不能自己选啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054d5421182, createdName=ms4000000973281563, createdTime=Tue Feb 07 19:27:47 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆)]

2023-05-24 ms7000000275097926 来自浙江省

偏重的研究方向：脑血管;纯生信
经验分享：这个杂志对于纯生信的文章接收吗

59 0

[GetPortalCommentsPageByObjectIdResponse(id=2096343, encodeId=b3f82096343d1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑血管疾病 经验分享：正在准备下一篇文章，再次用到这个系统决定写点经验回馈大家。临床小硕，一篇脑血管方面的文章。一审40天，审稿意见中肯严谨；按审稿意见修改15天后修回，20天后accept，差不多两个半月后online。研究生的第一篇文章，可以选择非OA不要版面费，现影响因子见长，目前2.667。加油吧医学僧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/d6e0b113f3f375444106bd57c5f62af3.jpg, createdBy=03155285285, createdName=V哈哈静, createdTime=Wed Oct 26 21:26:04 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147962, encodeId=fd48214e9626d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中;康复 经验分享：我师兄是雪落的誓言哈哈哈，我跟着他投的期刊。具体时间线：5月31日提交。6月02日 With Editor。6月05日 Under Review（邀请3，接受评审2）。6月26日RRC。6月26日 Major Revise（6条意见）。 7月07日提交修订，7月09日 With Editor，7月11日 Under Review（邀请1，接受评审1）。7月13日RRC。7月14日 Accept。一定要按照修改意见一条一条修改！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f78245022, createdName=ms6000000472127135, createdTime=Fri Jul 14 08:24:54 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2163616, encodeId=bc19216361616, content=请问下最近有投过综述的吗？投稿页面已经没有了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=136b8171073, createdName=ms9000000725000927, createdTime=Wed Oct 18 21:18:43 CST 2023, time=2023-10-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1231312, encodeId=f26612313122e, content=偏重的研究方向：房颤;心血管 经验分享：投稿后With Editor 4天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220708/c81f7dd923c54b8e84fe4716ff9fb706/a82b7266897b4d8c993cc7394b5d6767.jpg, createdBy=80462347615, createdName=122a44d6m85(暂无昵称), createdTime=Fri Jul 08 12:36:25 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138764, encodeId=db362138e640d, content=偏重的研究方向：脑血管;纯生信 经验分享：这个杂志对于纯生信的文章接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23cd8712869, createdName=ms7000000275097926, createdTime=Wed May 24 09:41:04 CST 2023, time=2023-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2139535, encodeId=35562139535ee, content=请问，最近有投这个杂志的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aaf8719470, createdName=ms2000000542857947, createdTime=Sun May 28 18:19:26 CST 2023, time=2023-05-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=571817, encodeId=39005e181781, content=审稿速度:1.0 经验分享：脑卒中病例对照研究。5.21 开始under review，6.2收到拒稿通知，只有一个审稿人，认为样本量太少，关联存在偶然性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee72530812, createdName=124ff737m56(暂无昵称), createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526443, encodeId=f4ab52644379, content=请问这个杂志接受脑血管病的实验文章不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac31694476, createdName=1de67449m99(暂无匿称), createdTime=Mon Aug 29 00:54:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554936, encodeId=743655493684, content=文章被接收了，修了2次，意见中肯，效率高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeOZwicjtKoFKia290ACJ5ic0JDJsfdTN5x3tqQKngx4zCfyc2O6pQkdEDlmXLaqKqCPwLvRaox0iaBg/132, createdBy=f6562183328, createdName=1207a24em51(暂无昵称), createdTime=Fri Apr 13 11:44:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113521, encodeId=af422113521a9, content=投稿时怎么默认通讯作者是一作呢？不能自己选啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054d5421182, createdName=ms4000000973281563, createdTime=Tue Feb 07 19:27:47 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆)]

2023-05-28 ms2000000542857947 来自山东省

请问，最近有投这个杂志的吗？

76 0

[GetPortalCommentsPageByObjectIdResponse(id=2096343, encodeId=b3f82096343d1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑血管疾病 经验分享：正在准备下一篇文章，再次用到这个系统决定写点经验回馈大家。临床小硕，一篇脑血管方面的文章。一审40天，审稿意见中肯严谨；按审稿意见修改15天后修回，20天后accept，差不多两个半月后online。研究生的第一篇文章，可以选择非OA不要版面费，现影响因子见长，目前2.667。加油吧医学僧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/d6e0b113f3f375444106bd57c5f62af3.jpg, createdBy=03155285285, createdName=V哈哈静, createdTime=Wed Oct 26 21:26:04 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147962, encodeId=fd48214e9626d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中;康复 经验分享：我师兄是雪落的誓言哈哈哈，我跟着他投的期刊。具体时间线：5月31日提交。6月02日 With Editor。6月05日 Under Review（邀请3，接受评审2）。6月26日RRC。6月26日 Major Revise（6条意见）。 7月07日提交修订，7月09日 With Editor，7月11日 Under Review（邀请1，接受评审1）。7月13日RRC。7月14日 Accept。一定要按照修改意见一条一条修改！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f78245022, createdName=ms6000000472127135, createdTime=Fri Jul 14 08:24:54 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2163616, encodeId=bc19216361616, content=请问下最近有投过综述的吗？投稿页面已经没有了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=136b8171073, createdName=ms9000000725000927, createdTime=Wed Oct 18 21:18:43 CST 2023, time=2023-10-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1231312, encodeId=f26612313122e, content=偏重的研究方向：房颤;心血管 经验分享：投稿后With Editor 4天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220708/c81f7dd923c54b8e84fe4716ff9fb706/a82b7266897b4d8c993cc7394b5d6767.jpg, createdBy=80462347615, createdName=122a44d6m85(暂无昵称), createdTime=Fri Jul 08 12:36:25 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138764, encodeId=db362138e640d, content=偏重的研究方向：脑血管;纯生信 经验分享：这个杂志对于纯生信的文章接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23cd8712869, createdName=ms7000000275097926, createdTime=Wed May 24 09:41:04 CST 2023, time=2023-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2139535, encodeId=35562139535ee, content=请问，最近有投这个杂志的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aaf8719470, createdName=ms2000000542857947, createdTime=Sun May 28 18:19:26 CST 2023, time=2023-05-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=571817, encodeId=39005e181781, content=审稿速度:1.0 经验分享：脑卒中病例对照研究。5.21 开始under review，6.2收到拒稿通知，只有一个审稿人，认为样本量太少，关联存在偶然性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee72530812, createdName=124ff737m56(暂无昵称), createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526443, encodeId=f4ab52644379, content=请问这个杂志接受脑血管病的实验文章不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac31694476, createdName=1de67449m99(暂无匿称), createdTime=Mon Aug 29 00:54:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554936, encodeId=743655493684, content=文章被接收了，修了2次，意见中肯，效率高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeOZwicjtKoFKia290ACJ5ic0JDJsfdTN5x3tqQKngx4zCfyc2O6pQkdEDlmXLaqKqCPwLvRaox0iaBg/132, createdBy=f6562183328, createdName=1207a24em51(暂无昵称), createdTime=Fri Apr 13 11:44:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113521, encodeId=af422113521a9, content=投稿时怎么默认通讯作者是一作呢？不能自己选啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054d5421182, createdName=ms4000000973281563, createdTime=Tue Feb 07 19:27:47 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆)]

2019-06-03 124ff737m56(暂无昵称)

审稿速度:1.0
经验分享：脑卒中病例对照研究。5.21 开始under review，6.2收到拒稿通知，只有一个审稿人，认为样本量太少，关联存在偶然性。

293 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2096343, encodeId=b3f82096343d1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑血管疾病 经验分享：正在准备下一篇文章，再次用到这个系统决定写点经验回馈大家。临床小硕，一篇脑血管方面的文章。一审40天，审稿意见中肯严谨；按审稿意见修改15天后修回，20天后accept，差不多两个半月后online。研究生的第一篇文章，可以选择非OA不要版面费，现影响因子见长，目前2.667。加油吧医学僧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/d6e0b113f3f375444106bd57c5f62af3.jpg, createdBy=03155285285, createdName=V哈哈静, createdTime=Wed Oct 26 21:26:04 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147962, encodeId=fd48214e9626d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中;康复 经验分享：我师兄是雪落的誓言哈哈哈，我跟着他投的期刊。具体时间线：5月31日提交。6月02日 With Editor。6月05日 Under Review（邀请3，接受评审2）。6月26日RRC。6月26日 Major Revise（6条意见）。 7月07日提交修订，7月09日 With Editor，7月11日 Under Review（邀请1，接受评审1）。7月13日RRC。7月14日 Accept。一定要按照修改意见一条一条修改！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f78245022, createdName=ms6000000472127135, createdTime=Fri Jul 14 08:24:54 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2163616, encodeId=bc19216361616, content=请问下最近有投过综述的吗？投稿页面已经没有了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=136b8171073, createdName=ms9000000725000927, createdTime=Wed Oct 18 21:18:43 CST 2023, time=2023-10-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1231312, encodeId=f26612313122e, content=偏重的研究方向：房颤;心血管 经验分享：投稿后With Editor 4天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220708/c81f7dd923c54b8e84fe4716ff9fb706/a82b7266897b4d8c993cc7394b5d6767.jpg, createdBy=80462347615, createdName=122a44d6m85(暂无昵称), createdTime=Fri Jul 08 12:36:25 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138764, encodeId=db362138e640d, content=偏重的研究方向：脑血管;纯生信 经验分享：这个杂志对于纯生信的文章接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23cd8712869, createdName=ms7000000275097926, createdTime=Wed May 24 09:41:04 CST 2023, time=2023-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2139535, encodeId=35562139535ee, content=请问，最近有投这个杂志的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aaf8719470, createdName=ms2000000542857947, createdTime=Sun May 28 18:19:26 CST 2023, time=2023-05-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=571817, encodeId=39005e181781, content=审稿速度:1.0 经验分享：脑卒中病例对照研究。5.21 开始under review，6.2收到拒稿通知，只有一个审稿人，认为样本量太少，关联存在偶然性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee72530812, createdName=124ff737m56(暂无昵称), createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526443, encodeId=f4ab52644379, content=请问这个杂志接受脑血管病的实验文章不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac31694476, createdName=1de67449m99(暂无匿称), createdTime=Mon Aug 29 00:54:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554936, encodeId=743655493684, content=文章被接收了，修了2次，意见中肯，效率高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeOZwicjtKoFKia290ACJ5ic0JDJsfdTN5x3tqQKngx4zCfyc2O6pQkdEDlmXLaqKqCPwLvRaox0iaBg/132, createdBy=f6562183328, createdName=1207a24em51(暂无昵称), createdTime=Fri Apr 13 11:44:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113521, encodeId=af422113521a9, content=投稿时怎么默认通讯作者是一作呢？不能自己选啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054d5421182, createdName=ms4000000973281563, createdTime=Tue Feb 07 19:27:47 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆)]

2016-08-29 1de67449m99(暂无匿称)

请问这个杂志接受脑血管病的实验文章不？

272 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2096343, encodeId=b3f82096343d1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑血管疾病 经验分享：正在准备下一篇文章，再次用到这个系统决定写点经验回馈大家。临床小硕，一篇脑血管方面的文章。一审40天，审稿意见中肯严谨；按审稿意见修改15天后修回，20天后accept，差不多两个半月后online。研究生的第一篇文章，可以选择非OA不要版面费，现影响因子见长，目前2.667。加油吧医学僧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/d6e0b113f3f375444106bd57c5f62af3.jpg, createdBy=03155285285, createdName=V哈哈静, createdTime=Wed Oct 26 21:26:04 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147962, encodeId=fd48214e9626d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中;康复 经验分享：我师兄是雪落的誓言哈哈哈，我跟着他投的期刊。具体时间线：5月31日提交。6月02日 With Editor。6月05日 Under Review（邀请3，接受评审2）。6月26日RRC。6月26日 Major Revise（6条意见）。 7月07日提交修订，7月09日 With Editor，7月11日 Under Review（邀请1，接受评审1）。7月13日RRC。7月14日 Accept。一定要按照修改意见一条一条修改！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f78245022, createdName=ms6000000472127135, createdTime=Fri Jul 14 08:24:54 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2163616, encodeId=bc19216361616, content=请问下最近有投过综述的吗？投稿页面已经没有了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=136b8171073, createdName=ms9000000725000927, createdTime=Wed Oct 18 21:18:43 CST 2023, time=2023-10-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1231312, encodeId=f26612313122e, content=偏重的研究方向：房颤;心血管 经验分享：投稿后With Editor 4天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220708/c81f7dd923c54b8e84fe4716ff9fb706/a82b7266897b4d8c993cc7394b5d6767.jpg, createdBy=80462347615, createdName=122a44d6m85(暂无昵称), createdTime=Fri Jul 08 12:36:25 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138764, encodeId=db362138e640d, content=偏重的研究方向：脑血管;纯生信 经验分享：这个杂志对于纯生信的文章接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23cd8712869, createdName=ms7000000275097926, createdTime=Wed May 24 09:41:04 CST 2023, time=2023-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2139535, encodeId=35562139535ee, content=请问，最近有投这个杂志的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aaf8719470, createdName=ms2000000542857947, createdTime=Sun May 28 18:19:26 CST 2023, time=2023-05-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=571817, encodeId=39005e181781, content=审稿速度:1.0 经验分享：脑卒中病例对照研究。5.21 开始under review，6.2收到拒稿通知，只有一个审稿人，认为样本量太少，关联存在偶然性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee72530812, createdName=124ff737m56(暂无昵称), createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526443, encodeId=f4ab52644379, content=请问这个杂志接受脑血管病的实验文章不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac31694476, createdName=1de67449m99(暂无匿称), createdTime=Mon Aug 29 00:54:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554936, encodeId=743655493684, content=文章被接收了，修了2次，意见中肯，效率高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeOZwicjtKoFKia290ACJ5ic0JDJsfdTN5x3tqQKngx4zCfyc2O6pQkdEDlmXLaqKqCPwLvRaox0iaBg/132, createdBy=f6562183328, createdName=1207a24em51(暂无昵称), createdTime=Fri Apr 13 11:44:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113521, encodeId=af422113521a9, content=投稿时怎么默认通讯作者是一作呢？不能自己选啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054d5421182, createdName=ms4000000973281563, createdTime=Tue Feb 07 19:27:47 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆)]

2018-04-13 1207a24em51(暂无昵称)

文章被接收了，修了2次，意见中肯，效率高！

234 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2096343, encodeId=b3f82096343d1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑血管疾病 经验分享：正在准备下一篇文章，再次用到这个系统决定写点经验回馈大家。临床小硕，一篇脑血管方面的文章。一审40天，审稿意见中肯严谨；按审稿意见修改15天后修回，20天后accept，差不多两个半月后online。研究生的第一篇文章，可以选择非OA不要版面费，现影响因子见长，目前2.667。加油吧医学僧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/d6e0b113f3f375444106bd57c5f62af3.jpg, createdBy=03155285285, createdName=V哈哈静, createdTime=Wed Oct 26 21:26:04 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147962, encodeId=fd48214e9626d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中;康复 经验分享：我师兄是雪落的誓言哈哈哈，我跟着他投的期刊。具体时间线：5月31日提交。6月02日 With Editor。6月05日 Under Review（邀请3，接受评审2）。6月26日RRC。6月26日 Major Revise（6条意见）。 7月07日提交修订，7月09日 With Editor，7月11日 Under Review（邀请1，接受评审1）。7月13日RRC。7月14日 Accept。一定要按照修改意见一条一条修改！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f78245022, createdName=ms6000000472127135, createdTime=Fri Jul 14 08:24:54 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2163616, encodeId=bc19216361616, content=请问下最近有投过综述的吗？投稿页面已经没有了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=136b8171073, createdName=ms9000000725000927, createdTime=Wed Oct 18 21:18:43 CST 2023, time=2023-10-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1231312, encodeId=f26612313122e, content=偏重的研究方向：房颤;心血管 经验分享：投稿后With Editor 4天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220708/c81f7dd923c54b8e84fe4716ff9fb706/a82b7266897b4d8c993cc7394b5d6767.jpg, createdBy=80462347615, createdName=122a44d6m85(暂无昵称), createdTime=Fri Jul 08 12:36:25 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138764, encodeId=db362138e640d, content=偏重的研究方向：脑血管;纯生信 经验分享：这个杂志对于纯生信的文章接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23cd8712869, createdName=ms7000000275097926, createdTime=Wed May 24 09:41:04 CST 2023, time=2023-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2139535, encodeId=35562139535ee, content=请问，最近有投这个杂志的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aaf8719470, createdName=ms2000000542857947, createdTime=Sun May 28 18:19:26 CST 2023, time=2023-05-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=571817, encodeId=39005e181781, content=审稿速度:1.0 经验分享：脑卒中病例对照研究。5.21 开始under review，6.2收到拒稿通知，只有一个审稿人，认为样本量太少，关联存在偶然性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee72530812, createdName=124ff737m56(暂无昵称), createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526443, encodeId=f4ab52644379, content=请问这个杂志接受脑血管病的实验文章不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac31694476, createdName=1de67449m99(暂无匿称), createdTime=Mon Aug 29 00:54:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554936, encodeId=743655493684, content=文章被接收了，修了2次，意见中肯，效率高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeOZwicjtKoFKia290ACJ5ic0JDJsfdTN5x3tqQKngx4zCfyc2O6pQkdEDlmXLaqKqCPwLvRaox0iaBg/132, createdBy=f6562183328, createdName=1207a24em51(暂无昵称), createdTime=Fri Apr 13 11:44:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113521, encodeId=af422113521a9, content=投稿时怎么默认通讯作者是一作呢？不能自己选啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054d5421182, createdName=ms4000000973281563, createdTime=Tue Feb 07 19:27:47 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆)]

2023-02-07 ms4000000973281563 来自重庆

投稿时怎么默认通讯作者是一作呢？不能自己选啊？

79 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务